A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin**Buserelin, Hoechst UK Ltd., Pharmaceutical Division, Hounslow, Middlesex, United Kingdom. for superovulation and in vitro fertilization

This publication has 16 references indexed in Scilit:

• Endocrine changes following pituitary desensitization with LHRH agonist and administration of purified FSH to induce follicular maturation
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal women
  Maturitas, 1985
• Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985
• Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985
• INDUCTION OF OVULATION FOR IN-VITRO FERTILISATION USING BUSERELIN AND GONADOTROPINS
  The Lancet, 1984
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
  Fertility and Sterility, 1984
• Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.
  BMJ, 1983
• A Standardised Multicentre Procedure for Plasma Gonadotrophin Radioimmunoassay
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
• Pregnancies in Humans by Fertilization in Vitro and Embryo Transfer in the Controlled Ovulatory Cycle
  Science, 1981
• Further Clinical Experience with Clomiphene Citrate
  Fertility and Sterility, 1968